NetworkNewsBreaks

WednesdayDec 04, 2019 3:38 pm

NetworkNewsBreaks – OTC Markets Group Initiates Discussion Regarding SEC’s Recent Rule Proposal

OTC Markets Group has invited the investment community to engage in a discussion regarding the SEC’s recent rule proposal on the Publication or Submission of Quotations Without Specified Information, which governs the public quoting of securities on OTCQX, OTCQB and Pink markets. In response to the proposal, OTC Markets recently published preliminary comments including several recommendations to enhance the effectiveness of the rule in the event that the SEC decides to implement the proposed amendments. OTC Markets also published a webinar on understanding the impact of the SEC’s Rule 15c2-11 Proposal. Among other changes, the rule proposal would require that up-to-date…

Continue Reading

WednesdayDec 04, 2019 2:44 pm

NetworkNewsBreaks – Predictive Oncology Inc.’s (NASDAQ: POAI) Platform Revolutionizing Cancer Treatment

Predictive Oncology (NASDAQ: POAI) is a knowledge-driven, precision-medicine company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery. An article discussing the company reads, “POAI’s platform, composed of over 150,000 patient tumors, harnesses the power of an individual patient’s tumor to help recommend the best treatment for that patient. This database, which houses evidence documenting actual drug responses of cancer patients’ individual tumors, uses artificial intelligence to create a valuable predictive tool for pharmaceutical companies and researchers. . . . Industry leaders believe that models utilizing patient-derived data powered by artificial intelligence will allow doctors to make…

Continue Reading

WednesdayDec 04, 2019 2:38 pm

NetworkNewsBreaks – Wonderfilm Media Corp.’s (TSX.V: WNDR) (OTCQB: WDRFF) Low-Risk Content Production Approach Provides Consistent Revenue Stream

Wonderfilm Media (TSX.V: WNDR) (OTCQB: WDRFF), a producer of high-quality feature films and episodic television with international appeal, has developed a low risk production process that supports steady, predictable revenues. A recent article discussing the company reads, “Soaring demand for content from streaming providers is fueling industry growth with established media giants in an all-out sprint to dominate some very lucrative revenue streams, a Bloomberg article states (http://nnw.fm/Ch98D). One segment of this industry, the global video on demand market, was valued at $28.9 billion in 2017 and is expected to reach $89.3 billion by 2026 at a compound annual growth rate…

Continue Reading

WednesdayDec 04, 2019 1:46 pm

NetworkNewsBreaks – SiTime Corp. (NASDAQ: SITM) Secures $64.3 Million in Initial Public Offering

SiTime Corporation (NASDAQ: SITM), a market leader in MEMS timing, has closed its initial public offering of 4,945,000 shares of its common stock, including 645,000 additional shares per the full exercise of the over-allotment option. According to the update, SiTime secured approximately $64.3 million in gross proceeds, with each of the shares sold at the public offering price of $13.00. ROTH Capital Partners acted as a co-manager for the offering. To view the full press release, visit http://nnw.fm/kHa7f About SiTime SiTime Corporation, a market leader in MEMS timing and a wholly-owned subsidiary of MegaChips Corporation, offers MEMS-based silicon timing system…

Continue Reading

WednesdayDec 04, 2019 1:27 pm

NetworkNewsBreaks – Co-Diagnostics, Inc.’s (NASDAQ: CODX) JV CoSara Secures Clearance for Five Diagnostic Assays to be Manufactured, Sold as IVDs from India-Based Facility

Co-Diagnostics (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced that its joint venture for manufacturing, CoSara Diagnostics Pvt Ltd, has obtained regulatory clearance for five tests to be manufactured and sold as in vitro diagnostics (“IVDs”) from its Ranoli, India-based facility. According to the update, the Saragene(TM) tests for Mycobacterium tuberculosis, malaria, hepatitis B, hepatitis C and human papillomavirus (“HPV”) meet requirements of the Central Drug Standard Control Organization Medical Device Rules 2017, File no. 29/Misc./3/2017-DC (292), to be manufactured and sold as IVDs. “India is soon to…

Continue Reading

WednesdayDec 04, 2019 1:02 pm

NetworkNewsBreaks – Soligenix, Inc. (NASDAQ: SNGX) Completes Enrollment in Pivotal Phase 3 SGX301 Clinical Trial in Treatment of Cutaneous T-cell Lymphoma

Soligenix (NASDAQ: SNGX), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today completion of patient enrollment in its Phase 3 "Fluorescent Light Activated Synthetic Hypericin" (“FLASH”) study for SGX301 (“synthetic hypericin”) in the treatment of cutaneous T-cell lymphoma (“CTCL”). According to the update, 169 subjects were successfully enrolled in the study following positive interim analysis, which included a prospectively defined, unblinded assessment of the study's primary efficacy endpoint by an independent Data Monitoring Committee (“DMC”). “We are pleased to have completed enrollment and look forward to…

Continue Reading

WednesdayDec 04, 2019 12:13 pm

NetworkNewsBreaks – CRISPR Therapeutics (NASDAQ: CRSP) Secures $315.2 Million in Underwritten Public Offering

CRISPR Therapeutics (NASDAQ: CRSP), a biopharmaceutical company focused on developing transformative gene-based medicines for serious diseases, has closed an underwritten public offering. According to the update, the offering consisted of 4,887,500 common stock shares, including 637,500 additional shares pursuant to the full exercise of the over-allotment option. CRISPR Therapeutics secured approximately $315.2 million in gross proceeds, with each of the shares sold at the public offering price of $64.50. ROTH Capital Partners acted as co-manager for the offering. To view the full press release, visit http://nnw.fm/S8Trq About CRISPR Therapeutics CRISPR Therapeutics is a leading gene editing company focused on developing…

Continue Reading

WednesdayDec 04, 2019 12:09 pm

NetworkNewsBreaks – GP Solutions, Inc. (GWPD) Featured in Article Discussing Controlled Environment Micro-Farms as Partial Solution Amidst Recent E. Coli Outbreak

GP Solutions (OTC: GWPD), the developer of modular automated micro-farms, may help in solving the E.coli crisis that is sickening dozens across America according to Business Management News. Per the article, dozens of people were infected across 19 states in the most recent E. coli outbreak stemming from lettuce harvested in California. Of those infected, their ages range from 3 to 89 years old, with 39 requiring hospitalization and six developing kidney failure. The article discusses forward-thinking companies that have developed new indoor farming methods, and references GWPD as it states, “One such company is GP Solutions. The company developed…

Continue Reading

WednesdayDec 04, 2019 11:22 am

NetworkNewsBreaks – Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI) Announces Establishment of At-The-Market Equity Program

Organigram Holdings (NASDAQ: OGI) (TSX: OGI) today announced that it has established an at-the-market equity program (“ATM Program”) that allows the corporation, at its discretion, to issue up to C$55,000,000 (or its U.S. dollar equivalent) of common shares from treasury to the public from time to time. Any common shares sold in the ATM Program will be sold through the Toronto Stock Exchange, the NASDAQ Global Select Market or any other marketplace on which the common shares are listed, quoted or otherwise traded, at the prevailing market price at the time of sale. The corporation, at its sole discretion, will…

Continue Reading

WednesdayDec 04, 2019 10:42 am

NetworkNewsBreaks – Trump Toaster and IMPeach Jam Available While Supplies Last

With this morning’s announcement, the innovators behind the new Trump Toaster and peach-flavored IMPeach Jam are on a mission to ‘Make Bread Great Again!’. With interchangeable plates featuring either President Trump’s face or his infamous “You’re Fired!” catchphrase, the Trump Toaster is being marketed as “a fantasy fulfilling political device no matter which side of the bread you prefer to butter.” With the holiday season in full effect, this toaster is sure to serve as a gift like no other. “This is toast… the likes of which the world has never seen,” Trump Toaster creator Debby Fireman stated in a…

Continue Reading